EX-2.1
from 8-K
73 pages
Dated November 2, 2022 Equity Purchase Agreement Among Reaction Biology Corporation, as Purchaser Vivopharm Pty, Ltd., as Seller Vyant Bio, Inc., as Parent and Vivopharm, LLC, as the Company
12/34/56
EX-2.1
from 425
111 pages
Agreement and Plan of Merger and Reorganization Among: Cancer Genetics, Inc., a Delaware Corporation; Cgi Acquisition, Inc., a Minnesota Corporation; and Stemonix, Inc., a Minnesota Corporation Dated as of August 21, 2020
12/34/56
EX-2.1
from 8-K
111 pages
Agreement and Plan of Merger and Reorganization Among: Cancer Genetics, Inc., a Delaware Corporation; Cgi Acquisition, Inc., a Minnesota Corporation; and Stemonix, Inc., a Minnesota Corporation Dated as of August 21, 2020
12/34/56
EX-2.1
from 8-K
83 pages
Secured Creditor Asset Purchase Agreement by and Among Interpace Biopharma, Inc. as the Buyer, Partners for Growth IV, L.P. as the Seller and Cancer Genetics, Inc. and Interpace Diagnostics Group, Inc. (Solely for Purposes of the Specified Sections) Dated as of July 15, 2019
12/34/56